The Enterprise Value as of December 2025 (TTM) for ABVC BioPharma, Inc. (ABVC) is 37.50M

According to ABVC BioPharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 37.50M. This represents a change of 7.48% compared to the average of 34.89M of the last 4 quarters.

ABVC BioPharma, Inc. (ABVC) Historical Enterprise Value (quarterly & annually)

How has ABVC Enterprise Value performed in the past?

The mean historical Enterprise Value of ABVC BioPharma, Inc. over the last ten years is 560.29M. The current 37.50M Enterprise Value has changed 569.26% with respect to the historical average. Over the past ten years (40 quarters), ABVC's Enterprise Value was at its highest in in the December 2015 quarter at 2.84B. The Enterprise Value was at its lowest in in the September 2023 quarter at 7.12M.

ABVC BioPharma, Inc. (ABVC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of ABVC BioPharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ABVC BioPharma, Inc. (ABVC) Average Enterprise Value

How has ABVC Enterprise Value performed in the past?

The current Enterprise Value of ABVC BioPharma, Inc. (ABVC) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ABVC BioPharma, Inc. (ABVC) Enterprise Value vs. Peers

How is ABVC’s Enterprise Value compared to its peers?

ABVC BioPharma, Inc.’s Enterprise Value is greater than Reviva Pharmaceuticals Holdings, Inc. (33.30M), greater than Grace Therapeutics, Inc. (29.31M), greater than LAVA Therapeutics N.V. (19.39M), greater than PDS Biotechnology Corporation (-26078149635.00), greater than Actinium Pharmaceuticals, Inc. (-7793855.00), less than Jupiter Neurosciences, Inc. (41.59M), greater than Tvardi Therapeutics, Inc. (18.21M), less than FibroGen, Inc. (103.87M), greater than Lantern Pharma Inc. (36.25M), greater than Xilio Therapeutics, Inc. (-59960772.00),

Build a custom stock screener for ABVC BioPharma, Inc. (ABVC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABVC BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ABVC BioPharma, Inc. (ABVC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ABVC BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.